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Summary
Two Dutch patients with liver phosphorylase kinase (PliK) 
deficiency were studied for abnormalities in the PhK liver 
a  (aL) subunit mRNA by reversed-tr a nscribed-PCR (RT~ 
PCR) and RNase protection assays. One patient, belonging 
to a large Dutch family that expresses X-linked liver PhK 
deficiency, had a C3614T mutation in the PhK <Xj. coding 
sequence. The C3614T mutation leads to replacement of
form of glycogen phosphorylase Co the active form, thus 
enabling liberation of glucose“!-phosphate from glycogen. 
PhK consists of four different subunits present in equimolar 
amounts in the hexadeeameric holoenxyme (aßyS)^ The 
catalytic site is located on the y  su bu it it. The a  and ß 
subunits are subjected to phosphorylation and dephosphor­
ylation and regulate the activity of the y subunit. The 5 
subunit is a calmodulin, conferring calcium sensitivity to
proline 1205 with leucine, which changes the composition the enzyme (foi reviews, see Pickett Gies and Walsh 1986,
of an amino acid region, containing amino acids 1 1 9 5 - Heilmeyer 1991). Isoforms of severa PhK subunits, en-
1214 of the PhK a , subunit, that is highly conserved in coded by different genes or generated by differential spl.c-
different species. The patient showed normal levels of PhK m?’ are kn°w n’ T le''e, are lsoforms of„th,e PhK ,a
a L mRNA. The second patient, from an unrelated family, subunit’ each ,encode1d ^  a seParafe 8ene> called “mu1scle 
was found to have a TCT (bp 4 1 9 -4 2 1 ) deletion in the ^  <Zancier et aL 1988 a,ld “1,ver « ’ <*■> (Davidson
PhK a , coding sequence, resulting in a phenylalanine 141 et aL 1992>’ according to their tissue-specific expression.
deletion. The same deletion was found in the PhK a, Both Senes are ocated 011 the X chromosonie and have
coding sequence from lymphocytes of the patient’s mother, been mapped to human Xql.2-13 (Francke et al. 1989) and
liver PhK deficiency in the two patients investigated.
Introduction
together with a normal PhK oti. coding sequence. The phc- Xp22*2-22,i (Davidson et al. IJJ2), respectively. The (Xm
nylalanine that is absent in the PhKai, coding sequence of 8ene CI1C°  ^ two ocm subunits, a M and 0Cm, t int
the second patient is a highly conserved amino acid be- are generated by diffeiential splicing (I Iaimann etal. UJ1).
tween species. Both the C3614T mutation and the T C T  The <*m subunit is expressed in fast-glycolytic muscle fibers,
(bp 419 421) deletion were not found in a panel of 80 while the subunk is the predominating isoform in slow-
control X chromosomes. On the basis of these results, it oxidative and fast-oxidative glycolytic muscle fibers and in
is postulated that the mutations found are responsible for ]ieart (Jennissen and Heilmeyer 1974; Cooper et al. 1980).
The at, gene encodes an ai, subunit but* probably not an
a[, subunit. The aj, cDNA has been isolated from a rabbit
liver cDNA library (Davidson et al. 1992), but the existence
of an a(. cDNA was not reported. As for the (Xm subunit,
tissue-specific differential splicing has been found for the ß
Phosphorylase kinase (PhK; ATP:phos, phosphorylase-/; subunit, whereas only a single gene encoding this subunit
phosphotransferase; E.C.2.7.1.38) is a key enzyme in the >s known (Harmann et al. 1991). I wo .separate genes are
regulation of glycogen breakdown. After a glucagon or found encoding the muscle (Jones et al. 1990) and testis
adrenaline stimulus, PhK is activated by cAMP-dependent (Calalb et al. 1992) y  subunits. The genes for the ß and
protein kinase. Activated PhK, in turn, converts the inactive muscle y  subunits have been mapped to human chromo-
some 16q l2 -q l3  (Francke et al. 1989) and human chromo­
some 7pl2-q21 (Jones et al. 1990), respectively. Chromo­
somal localization of the testis y  gene is unknown. The 
complexity of PhK subunit expression is reflected in the 
many forms of PhK deficiency that have been described. 
The most frequently occurring form is human X-linked 
liver PhK deficiency. In the majority of cases, this deficiency
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is also detectable in erythrocytes and leukocytes (Huijing 
and Fernandes 1969; Schi mice et al. .1973; Lederer et al. 
1975). In some cases, however, normal activity is found in 
blood cells (Alvarado et al. 1988; Balcker et al. 1991). 
Other forms of PhK deficiency that have been described 
are the autosomal recessive form of liver PhK deficiency 
(Lederer et al. 1975), combined liver and muscle PhK defi-
tance, and from the mother of this patient (M5). P5 is the 
first child and son of nonconsanguineous parents. During 
pregnancy the mother suffered from diabetes. Birth was 
normal, but the child had a hypoglycemic event in the 
perinatal period. He presented, at 6 mo of age, with hepato­
megaly. There was a slight delay in motor development, 
hypertriglyceridemia, and elevation of liver transaminases.
ciency with an autosomal recessive mode of inheritance PhK activity (measured as described by Lederer et al. 1975) 
(Lederer et al. '1980; Bashan et al. 1981), isolated heart was <0/1 in erythrocytes (normal values 3.2 ± 0.4), sug- 
PhK deficiency (Mizuta et al. 1984; Servidei et al. 1988), gesting the diagnosis of liver PhK deficiency.
and isolated muscle PhK deficiency (Ohtani et al. 1982; CDNA Sequence of the Human PhK a L Subunit
Abarbanel et al, 1986), both with unknown modes of in- A human liver cDNA library was constructed using a
heiitance. The deficiency of heait PhK activity is the only bacteriophage Lambda vector (Lambda Zap; Stratagene).
form that is associated with early death; the other forms This library was screened with a human PhK a,. cDNA
have less severe symptoms and aie compatible with life (foi probe pCI (Hendrickx et al. 1993). Two overlapping
review, see van den Berg and Bei get 1 J>90), Apait fiom clones, containing the complete coding sequence of the hu~
these forms of PhK deficiency found in humans, seveial mnn p^ ^  subunit, were isolated and sequenced. The
deficiencies have been described in mouse (Lyon and Porter 
1963; Cohen et al. 1976; Varsanyi et al. 1980) and rat 
(Malthus et al. 1980). X-linked muscle PhK deficiency of 
the I-strain mouse was recently shown to be caused by a 
single-base-pair insertion in the coding sequence of the PhK
complete cDNA sequence of the human PhK ai. subunit 
will be published elsewhere. The human PhK oti, cDNA 
sequence has been submitted to the EMBL data bank. The 
accession number is X80497.
a M subunit (Schneider et al. 1.993), Human X-linked liver RTnPCR and Sequencing
PhK deficiency has been mapped to Xp22 (Willems et al. 
1991; Hendrickx et al. 1993), i.e., to the same region to
Total RNA was isolated from lymphocytes and EBV- 
transformed lymphocytes by using RNA-SRrM (Biogenesis)
which the gene encoding the PhK aL subunit has been according to the manufacturer s instructions. For first-
mapped (Davidson et al. 1992). Therefore, the gene encod strand cDNA synthesis, 1.0 jL.ig of total RNA was used.
ing the PhK ot|. subunit is a strong candidate gene for X- primers used in^the reaction were oligo-dT or HLa3r
linked liver PhK deficiency. The finding of either mutations (TCACAGTCCACGTCACCATG, complementary to nt 
in the PhK a f. coding sequence or a diminished expression 2282 to 2263 of human PhK cXi. cDNA). First-strand cDNA
of PhK subunit mRNA would enhance the candidacy 
of this gene. In this study we have analyzed the coding 
sequence from the PhK a { subunit and investigated the 
PhK ocj, mRNA expression in Epstein-Barr virus (EBV)-
transformed lymphocytes from two unrelated Dutch pa­
tients. The first patient is a member of a family that ex­
presses X-linked PhK deficiency, while the second patient 
is an isolated case of liver PhK deficiency. Two different 
mutations were found in the PhK a L coding sequences of 
the two patienüs, leading to an amino acid substitution in 
the PhK cXj, subunit ot the first patient and to an amino 
acid deletion in the PhK a t subunit of the second patient.
The relation of these mutations to the expression of liver 
PhK deficiency is discussed.
Patients, Material, and M ethods
Patients and Material
synthesis was performed using reverse transcriptase (Gibco 
BRL) according to the manufacturer’s instructions. PCR 
amplification of overlapping fragments was essentially as 
described by Saiki et al. (1988). The primer pairs used in
the PCR-reactions are as follows: HLcxlf (ATCCCAAGA- 
ACCGACTAAGG; nt -1 1 9  to -100) and HLodr (CTT- 
TGGCCACCTGTCT; complementary to nt 295 to 280); 
H la2 f (AGGCCTACGAGCTGGAG; nt 218 to 234) and 
HLa2r (GTGTTTCCTCAATAAGTC; complementary to 
nt 1374 to 1357); HLoc3f (TCCTTGCCGCTGGTG- 
AAATC; nt 1250 to 1269) and HLa3r (TCACAGTCC- 
ACGTCACCATG; complementary to nt 2282 to 2263); 
HLa4f ( C A CïT CCTG AT A GT GATT C A G ; nt 1908 to 
1927) and HLot4r (GCAAACTrGATCTCATGCGG; 
complementary to nt 3362 to 3343); and HLa5f (GGA- 
GCCTGAACTGCTCAGGA; nt 2789 to 2808) and 
HLaSr (AGAGTCCGTGAGACCAGATG; complemen­
tary to nt 3990 to 3971). The PCR products were se-
Lymphocytes and EBV-transformed lymphocytes were <-luenced directly by using the PUC sequencing kit (Boeh-
obtained from four patients (PI—P4) belonging to a large j in8ei Manmeim) accoiding to the manufactutei s instiuc-
Dutch family expressing X-linked liver PhK deficiency,
which has been extensively described (Huijing and Fernan- Restriction Analysis of PCR-Amplified Genomic DNA Fragments
tions.
des 1969; Willems et al. 1990), from a Dutch boy (P5)
with liver PhK deficiency and unknown mode of inheri-
Genomic DNA was isolated from EBV-transformed lym­
phocytes of P1-P5 and from lymphocytes of P5, M5, and
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40 female controls, by established methods. A 102-bp ge- Results
nomic DNA fragment was amplified from DNA of P1-P4 
and from DNA of 40 female controls, with PCR as de­
scribed above, using HLaóf (GCCACTTCTTTTATG-
Activities of PhK in E&V-Tronsformed Lymphocytes
PhK activity in control lymphocytes was 132.2 ± 16.4
ACAGC; nt 3590 to 3609) and H L a6r CCGAATTGG- U/mg protein (« =  4). PhK activity in control EBV-trans-
GCAACAATTCC; complementary to nt 3691 to 3672) as formed lymphocytes was 92.2-119.9  U/mg protein [n
primer pair for the reaction. The PCR products were di- = 2). Thus PhK activity in hBV-translormed lymphocytes
gested with the restriction enzyme DdeI (Boehringer) (rec- of normal individuals was comparable to PhK activity in
ognizing the sequence CTNAG) and then were analyzed control lymphocytes. I he PhK activities of the hBV-lrans-
on a 3% agarose (Pharmacia) gel. A second 101-bp DNA formed lymphocytes of P1-P4, all belonging to a large
fragment was PCR-amplified from DNA of P5, M 5 , and Dutch family expressing X-linked liver PhK deficiency, vary
40 female controls, with HLa7f (TACAACACCGCC- from 4.2 to 20.9 U/mg protein and are <20%  of normal.
ACCTGTGG; nt 346 to 365) and HLa7r (GTCATCTGG- Thl-' activity in EBV-transformed lymphocytes of P5, an
GCCAGGAAGAG; complementary to nt 446 to 427) as isolated case of liver PhK deficiency, was 13% ol: normal,
primer pair for the reaction. The PCR products were di- ^  was likely, therefore, that all batches of hBV-transformed
gested with Ksp6321 (Boehringer) (recognizing the se- lymphocytes from patients with liver PhK deficiency investi-
quence CTCTTCN) and were analyzed on a 3% agarose 8«ted were expressing the deficient gene and could be used
(Pharmacia) gel.
RNase Protection Assay
to search for mutations in the coding sequence of the PhK 
ai. subunit and to establish the effect of possible mutations 
on PhK a L subunit mRNA expression.
Total RNA from EBV-transformed lymphocytes and Mutations in the Coding Sequence from the PhK a L Subunit
normal lymphocytes was isolated as described above. In The complete coding sequences of the PhK 0C|, subunit
each experiment 10 fig of RNA (based on E26u measure- from PI andP5 were sequenced after PCR-amplification ol
ments and confirmed with gel electi.ophoi.esis) was used. overlapping fragments from reverse-transcribed total RNA
A PhK a L cDNA clone of 352 bp, containing bases 7 4 7 - from EBV-transformed lymphocytes. The obtained PCR
1098 of the coding sequence of die PhK otLi subunit, was products were not cloned into a vector* but were sequenced
cloned into a Bluescript plasmid. Full-length antisense RNA directly to exclude erroneous mutations generated by Tacj
probe was made by using T , RNA polymerase (25 U/ polymerase during amplification, The patient sequences
reaction; RT Biotechnology) in a reaction mixture con- were comparec[ w ith ehe cloned PhK a,. cDNA sequences
taining 0.25 |Xg of linearized probe, 40 mM Tris HCl pH aiK| w ;t h the PhK a,, coding sequences of control EBV-
8.0, 7 mM MgCl2, 25 mM NaCl, 500 pM  ATP, 500 \xM transformed lymphocytes. In P I, a C36M T mutation was
CTP, 500 pM GTP, 10 mM D IT , 2 niM spermidine, 0.5 found, leading to an amino acid replacement of proline
U of RNAsin (Promega), and 5 flM MMabeled U l P (600 1205 by leucine (fig. 1). No other deviations from the
Ci/mmol; Amersham), in a total volume of 15 pi. The normal cDNA sequence were seen. For further analysis of
mixture was incubated for 3 h a t  room temperature. Su bse- t|ie C36T4T mutation, the PCR fragment harboring the
• w  J 9  i m  i m i  *  W A  t  É  4  M
quently, 1 U of RNase-free DNase (Promega) was added, 
and the mixture was incubated for another 15 min at 37°C. 
The labeled probe was purified by extraction with an equal 
volume of phenol/chloroform, followed by two extractions 
with an equal volume of chloroform alone, and was precip­
itated with 2.5 vol of ethanol. The probe was redissolvcd 
in water and was diluted to 20 ,000  epm/|il. The probe was 
used on the same day that it was prepared, and for each 
experiment 1 pi of diluted probe was used.
The RNase protection assays were carried out by using 
the RPAIIIM kit (Ambion) according to the manufacturer’s
mutation (nt 3362 to 3990) was amplified with RT-PCR 
from total RNA from EBV-transformed lymphocytes of 
P2-P4, all patients from the same family, followed by se­
quencing. We found that the mutation was also present in 
the PhK (X| coding sequences from P2-P4. The C3614T 
mutation adds a Ddc\ restriction site to the PhK (X( coding 
sequence (fig, Iß)« When a genomic DNA fragment of 102 
bp harboring the mutation was PCR-amplified from DNA 
of P 1-P 4  and was digested with Dde I (see Patients, Mate­
rial, and Methods), a 76-bp and a 26-bp fragment were 
generated (fig. 2A), When the corresponding DNA sc-
instructions. The protected fragments were run on a 5% quence was amplified from a panel of HO normal X chm
polyacrylamide gel. After drying, the gel was exposed for 
72 -96  h to a film (X-OMAT™ AR; Kodak). The gels 
were then analyzed with a phosphor imager (Molecular 
Dynamics), and the signal was quantitated by delineating a 
rectangle around the signal, followed by volume integration 
with the Image Q uan t1 M (Molecular Dynamics) program.
mosomes, the fragment was not digested by Ddel (results 
not shown).
In P5 a 3-bp deletion was found in PhK (xt cDNA ampli­
fied from total reverse-transcribed RNA from EBV-trans- 
formed lymphocytes. A TCT triplet corresponding to bp 
419-421 was absent (fig. 3). This leads to deletion of phc-
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Expression of PhK at Subunit mRNA in EBV-Transformed 
Lymphocytes
Expression of the PhK (Xi. mRNA was examined with 
RNase protection assays, using a uP-labeled antisense 
RNA probe of 352 bp. The probe was chosen in a region 
that contained no known splicing variant and in such a 
way that neither the C3614T mutation nor the TCT (bp 
419-421) deletion was located within the probe region, 
The relative amount of PhK oti. mRNA was measured as 
described above (see Patients, Material, and Methods). The 
expression of PhK a*. mRNA in P1-P4 varied from 76% 
to 96% of expression in control EBV-transformed lympho­
cytes (fig, 4), The mRNA expression for the PhK a L sub-
A
PI 3600 TAT GAC AGC GCT CTG AGT GGG
D S A
Figure I Partin! coding sequence of the PhK CC|. subunit of PI, 
showing the C3614T mutation (A) and the influence of the mutation on 
restriction by Dde I and amino acid sequence (ß), A t Part of the PhK CX[ 
coding sequences of PI, P5, and a control (lanes C). The G ’s of the three 
sequences are shown in three adjacent lanes, with the order in which they 
are brought onto the gel written above the lanes. The same is done for the 
A’s, T s ,  and Cs. The C3614T mutation {arrow), visible in the sequence of 
PI, was not present in the PhK 0C], coding sequence of P5. B, Influence 
of the C3614T mutation on digestion by Dde\ and amino acid sequence* 
The amino acid sequences are presented above and below the cDNA 
sequences of the control and of P I ,  respectively. The Ddel restriction site 
(CTNÀG), generated by the mutation, is underlined in the PI cDNA 
sequence. The C3614T mutation in the sequence of PI is marked with 
an asterisk (*).
nylalanine 141. No other deviations from the normal PhK 
0Ci. sequence were detected. The TCT (bp 419-421) dele­
tion was also found in the PhK a t, coding sequence from 
lymphocytes of the same patient and from lymphocytes of 
the mother, where both a normal sequence and a sequence 
lacking the TCT triplet were found (fig. 3). The intensity 
of the signal in lymphocytes of the mother was the same 
for the normal and mutated sequences. Because of the TCT 
deletion, a Ks/;632I restriction site Ls lost from the PhK oct 
coding sequence (fig. 30). After PCR amplification of a 
genomic DNA fragment of 101 bp, comprising bp 4 1 9 - 
421 of the PhK (Xi. coding sequence, followed by digestion 
by Ksp63Zl (see Patients, Material, and Methods), two 
fragments, one of 79 bp and one of 22 bp, will normally 
be generated. When DNA of 40 female controls was used 
as template for the PCR reaction, all 1.01-bp fragments 
were digested by Ksp632L When the corresponding frag­
ment from DNA of P5 was treated with Ksp6321, no diges­
tion of the fragment was seen. Amplified DNA of the 
mother showed a normal digested and a mutated fragment 
(fig. 2B).
bp
126
75
51
B
bp
126
75
51
1
*
1
will#" ••HI WM-
Figure 2 PCR-amplification of PhK (Xj. DNA fragments, followed 
by digestion with Ddel (/I) or Ksp6321 (B) and analysis on agarose gels, /\, 
DdiA cutting of a PCR-amplified 102-bp fragment (described in Patients, 
Material, and Methods) from DNA of PI harboring the C36 14T mutation 
(lane 3). The corresponding DNA fragment is not digested by Ddel if 
control DNA is used as a template {arrow; lanes 2, 4, and 5) and has the 
same length as the untreated PCR fragment (lane 1), The band marked 
with an asterisk (*) is a nonspecific PCR product that is also seen in the 
negative control, B, Ksl)632l restriction site present in a PCR-amplified 
PhK a  î, fragment (described in Patients, Material, and Methods) of control 
DNA (lane 4) but not found in the corresponding DNA fragment of P5 
(lane 2). In the mother, two fragments are seen (lane 3), a normal fragment 
(amno) and a fragment that contains the TCT deletion. The untreated 
PCR product is shown in lane 1.
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L  L F
Figure 3 Partial coding sequence of the PhK a ir subunit of P5, 
showing a TCT deletion (A) and influence of the mutation on restriction 
digestion by Ksp632\ and on amino acid sequence (B ), A, RT-PCR- 
amplified PhK Ci\. cDNA sequences from HBV-transformed lymphocytes 
of P5, PI, a control (lanes C) and the mother of P5 (M5), showing a 
TCT (bp 419-421) deletion from the sequence of P5 and from one of 
the two coding sequences of the mother. The sequences of P I ,  P5, and 
the control are brought onto the gel in the same way as described in fig. 
1 and are shown in the left-hand panel. The sequence of the mother is 
shown in the right-hand panel, ß, Influence of the TCT (bp 419—421) 
deletion from the PhK (X|. coding sequence of P5 on digestion by Ksp6321 
and on amino acid sequence. The amino acid sequences corresponding 
to the cDNA sequences of the control and of P5 are written above anil 
below the cDNA sequences, respectively. The Ksf>h32\ restriction site is 
underlined in the control sequence. The bases marked with an asterisk 
(*) are deleted in the sequence of P5.
unit in EBV-transformed 
normal.
:es of P5 was 81% of
Discussion
A
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Figure 5 Amino acid sequence sitnilarities of the two regions of 
the human PhK aj. coding sequence containing the mutations found in 
PI (A) and P5 (B). A, Similarity comparison of the region containing 
proline 1205. Proline 1205, which has been exchanged for a leucine in 
the PhK ai. coding sequence of P I, is a highly conserved amino acid that 
is present in all PhK a  subunits sequenced so far. The region comprising 
the mutation is also homologous to amino acids 1054-1079  of the rabbit 
muscle ß sequence, and the proline is conserved in this rabbit muscle 
ß (RMß) sequence. B, Similarity comparison of the region containing 
phenylalanine 141. Phenylalanine .141, which is deleted in the PhK cx( 
coding sequence of P5, is conserved between human liver a  (HLu) and 
rabbit liver <x (RLa) and is substituted by a tyrosine in human muscle u  
(HM a), rabbit muscle a  (RMcx), mouse muscle a  (M M a), and rabbit 
muscle ß (RMß), which is a conservative substitution. The amino acid 
sequence surrounding the I Il.u phenylalanine 141 is highly conserved in 
all the sequences mentioned, including the RM ß sequence. HLu human 
liver cx; R L a  ~  rabbit liver a  (Davidson et al. 1992); H M u  -  human 
muscle a  (Wllllrich et al. 1993); R M u  -  rabbit muscle a  (Zander et al, 
1988); M M a  “  mouse muscle a  (Schneider et al. 1993); and RMß -  rab­
bit muscle ß (Kilimann et al. 19H8),
P5 P1 P2
Two different mutations in the human PhK a L subunit quenceofP l shows a C3614T point mutation, which leads 
coding sequence were found in two unrelated kindreds. PI to exchange of proline 1205 for leucine (tig, I). The muta- 
belongs to a Dutch family expressing X-linked liver PliK tion was also present in the PhK CXi, coding sequences of 
deficiency in several generations. The PhK (Xi. coding sc- three affected family members of P L Proline 1205 is com­
pletely conserved between species and lies in a highly con­
served amino acid region of the tt subunits, in the middle 
of a group of seven amino acids that are conserved in the 
human and rabbit liver (X protein sequences and in the 
human, rabbit, and mouse muscle a  subunits (fig, 5/1). 
Furthermore, this region shows amino acid homology with 
amino acids 1054-1079 of the rabbit muscle ß subunit 
(46% identity and 19% conservative substitutions; Kili- 
mann et al. 1988), and proline 1205 (amino acid 1059 of 
the ß subunit) is conserved in the rabbit muscle ß sequence 
((ig< 5/\). No other mutations in the entire coding sequence 
of EBV-transformed lymphocyte PhK CXi. have been found. 
Furthermore, the mutation was not detected in DNA of
Figure 4 RNase protection assay of the PhK Uj subunit in LHV- 
transformed lymphocytes from three patients with liver PhK deficiency. 
The RNase protection assay was performed as described in Patients, Mate­
rial, and Methods. The amounts of the 352-bp protected fragment in 
LHV-transformed lymphocytes of the patients [amncn lanes 2 - 4 )  are com­
parable to the amount found in control UHV-transfonned lymphocytes 
(lane 1 ).
386 A m ,] . Hum. Genet. 56:381 -3 87 , ƒ995
40 female controls, indicating that the mutation is not a PhK a L. subunit. It is suggestive, therefore, that X-linked
common polymorphism. Another possible reason for the 
deficiency might be a diminished expression of PhK a*.
liver PhK deficiency will be molecularly heterogeneous. The 
search for mutations in additional families will be ham-
mRNA, caused by a mutation either in the promoter region pered because of the large size of the mRNA that exceeds
of the gene or in the 5 ' UTR of the mRNA. We found that 4,500 nt. However, if carrier detection is sought in other
there is a normal level of PhK aL mRNA expression in families in which liver Phk deficiency is diagnosed, it will
EBV-transformed lymphocytes of PJ.~P4, as was deter- be necessary to establish the underlying genetic defect in
mined with RNase protection assays (fig. 4). This was each of these families, 
found both when the results were based on quantitation
of total RNA by measuring E2r,o values and when a human 
actin antisense mRNA probe was used as a control for 
estimation of the expression level of PhK a L mRNA ( results 
not shown). This indicates that there is a normal transcrip­
tion of the PhK (Xi, gene in EBV-transformed lymphocytes 
of PI “ P4. Thus it is highly probable that the C3614T point 
mutation in the human liver PhK CXi, subunit causes the 
defect in this family with X-linked PhK deficiency.
In P5, who is suffering from liver PhK deficiency with 
unknown mode of inheritance, a TCT triplet was missing 
in the PhK a L coding sequence from EBV-transformed lym­
phocytes, giving rise to a phenylalanine 141 deletion. The 
same deletion was found in the PhK (Xl coding sequence 
from lymphocytes of the patient and from lymphocytes of 
the mother, in the latter together with a normal coding 
sequence (fig. 3). This implies that the mother is a carrier 
for the mutation. The mutation was not found in DNA 
from a panel of 80 normal X chromosomes, again indicat­
ing that the deletion is not commonly found in the normal 
population. Phenylalanine 141 lies in an amino acicl region 
that is highly conserved in human and rabbit liver a  protein 
sequences and in human, mouse, and rabbit muscle a  pro­
tein sequences (fig. 5B), The function of this region is un­
known. The region is also highly homologous with amino 
acids 168-189 of the rabbit PhK ß subunit (59% identity 
and 27% conservative substitutions; Kilimann et al. 1988). 
The PhK ai, mRNA expression in EBV-transformed lym­
phocytes of P5 was normal, as estimated with RNase pro­
tection assays (fig. 4). This result correlates with the finding 
that in lymphocytes of the mother the signals of the mu­
tated and the normal PCR-amplified sequences were of 
equal strength (fig. 3A), It is very likely therefore that the 
TCT deletion is responsible for the liver PhK deficiency in 
this patient, i.e., that he is suffering from the X-linked form 
of liver PhK deficiency.
Knowledge of the mutations in the PhK a L coding se­
quences of two kindreds expressing liver PhK deficiency 
enables both unambiguous diagnosis of future patients be­
longing to these kindreds and carrier detection. Genetic 
testing of family members is greatly facilitated by the fact 
that both mutations give rise to an altered restriction pat­
tern of the PhK a L coding sequence (fig. 2). In conclusion, 
our results strongly indicate that the X-linked form of liver 
PhK deficiency in two unrelated kindreds is caused by two 
different single mutations in the coding sequences of the
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